DEADLINE NEXT WEEK: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Contact the Firm Before February 9, 2026
globenewswire.com
Want to monitor RVMD?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor RVMDrevolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.